Abstract
Influenza is an infection of the upper respiratory tract caused by influenza virus. Neuraminidase (NA) plays an essential role in replication and infection of influenza virus. It is considered as a suitable target for antivirus agents development. Several potent NA inhibitors (NAIs) developed by using structure-based rational design have been widely used in clinic for treatment of influenza. However, the emergence of NA inhibitor-resistant virus mutations significantly limit their effectiveness. The molecular basis of virus resistance to NAIs has been a focus of intensive research. This review highlights recent progress in rational design and resistance mechanism of NAIs. We hope this review will be useful to not only researchers who are interested in developing novel NAIs but also clinical pharmacists.
Keywords: Neuraminidase (NA), anti-influenza agents, computer-aided drug design, resistance
Current Medicinal Chemistry
Title:Recent Advances in the Structure-Based Design of Neuraminidase Inhibitors as Antiinfluenza Agents
Volume: 19 Issue: 34
Author(s): Yuanyuan Shan, Ying Ma, Maoyi Wang and Yalin Dong
Affiliation:
Keywords: Neuraminidase (NA), anti-influenza agents, computer-aided drug design, resistance
Abstract: Influenza is an infection of the upper respiratory tract caused by influenza virus. Neuraminidase (NA) plays an essential role in replication and infection of influenza virus. It is considered as a suitable target for antivirus agents development. Several potent NA inhibitors (NAIs) developed by using structure-based rational design have been widely used in clinic for treatment of influenza. However, the emergence of NA inhibitor-resistant virus mutations significantly limit their effectiveness. The molecular basis of virus resistance to NAIs has been a focus of intensive research. This review highlights recent progress in rational design and resistance mechanism of NAIs. We hope this review will be useful to not only researchers who are interested in developing novel NAIs but also clinical pharmacists.
Export Options
About this article
Cite this article as:
Shan Yuanyuan, Ma Ying, Wang Maoyi and Dong Yalin, Recent Advances in the Structure-Based Design of Neuraminidase Inhibitors as Antiinfluenza Agents, Current Medicinal Chemistry 2012; 19 (34) . https://dx.doi.org/10.2174/092986712804143358
DOI https://dx.doi.org/10.2174/092986712804143358 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Possible Roles of Reg Family Proteins in Pancreatic Islet Cell Growth
Endocrine, Metabolic & Immune Disorders - Drug Targets Side Effects of Clozapine and Some Other Psychoactive Drugs
Current Drug Safety Pharmacological Targeting of Neuronal Kv7.2/3 Channels: A Focus on Chemotypes and Receptor Sites
Current Medicinal Chemistry Trizbenzim, Cu-Trizbenzim and Zn-Trizbenzim as G-Quadruplex Inducing and Stabilizing Compounds on Human Telomeric Sequence and their Anticancer Properties
Anti-Cancer Agents in Medicinal Chemistry Development of a Web-Enabled SVR-Based Machine Learning Platform and its Application on Modeling Transgene Expression Activity of Aminoglycoside-Derived Polycations
Combinatorial Chemistry & High Throughput Screening Molecules of Natural Origin, Semi-synthesis and Synthesis with Anti-Inflammatory and Anticancer Utilities
Current Pharmaceutical Design New Inhibition Detection Method to Evaluate the Human Salivary Alphaamylase Activity of Some Drugs, Molecular Docking, and SAR Studies
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review
Current Gene Therapy Discovery and Optimization of a Series of Sulfonamide Inverse Agonists for the Retinoic Acid Receptor-Related Orphan Receptor-α
Medicinal Chemistry Arylazolylthioacetanilide. Part 11: Design, Synthesis and Biological Evaluation of 1,2,4-triazole Thioacetanilide Derivatives as Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors
Medicinal Chemistry Self-assembly of Block Copolymers Under 3D Confinement: Toward Nanostructured Particles
Nanoscience & Nanotechnology-Asia Anticancer Drug Discovery from the Marine Environment
Recent Patents on Anti-Cancer Drug Discovery ATP Synthase, an Emerging Target in TB Drug Discovery: Review of SAR and Clinical Pharmacology of Diarylquinoline Inhibitors
Current Drug Targets Critical Clinical Evaluation of COVID-19 Patients with Tuberculosis in the Indian Sub-Continent
Current Drug Safety Antimicrobial and Chemopreventive Properties of Herbs and Spices
Current Medicinal Chemistry Synthesis, Characterization and Evaluation of 1,3-Bisindolyl-2-Propen-1- One Derivatives as Potent Anti-Breast Cancer Agents
Current Bioactive Compounds Patent Selections
Recent Patents on Drug Delivery & Formulation Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study
Current Molecular Medicine Piecing the Fragments Together: Dynamical Insights into the Enhancement of BRD4-BD1 (BET Protein) Druggability in Cancer Chemotherapy Using Novel 8-methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives
Current Pharmaceutical Biotechnology COVID-19 Severity: Lung-Heart Interplay
Current Cardiology Reviews